Scientific Program

3rd International Congress on Psychopharmacology

Scientific Program (PDF) Download

Shortcuts

...

Salon A |

12 March 2009

10:30-11:15

Moderator:

Esat GÖKTEPE

Clozapine: 55 years after as post discovery and its illumination of refractory schizophrenia

Y. MELTZER

11:30-12:15

Moderator:

Ümit YAŞAR

Novel pharmacotherapies in treatment of depression: Oxytocin for treatment of depression

Ziad NAHAS

13:00-14:30

Symposium-1: Pharmacogenetics, pharmacoresistance and therapeutic goals

Educational Updates Track

Moderators:

Alaattin DURAN

Hasan HERKEN

Epigenetic mechanisms of psychiatric disorders and targets in treatment

Cengiz BAŞOĞLU

Effects of genetic differences on psychiatric disorders and treatment: "Individualized pharmacotherapy:" Myth or truth?

Nevzat TARHAN

What is the role of drug metabolisms in treatment resistance?

Ümit YAŞAR

Use of pharmacoEEG and EEG on drug selection and efficiency assessment : Myth or truth?

Kemal ARIKAN

Pharmacoresistance in psychiatry

Feyza ARICIOĞLU

14:45-16:15

Symposium-4 : From past to future: Resistance in schizophrenia, where are we and what can be done?

Symposia - Educational Updates Track

Moderators:

Erdal IŞIK

Ertan TEZCAN

Description and neurobiology of treatment resistance in schizophrenia

Kâzım YAZICI

Relationship of early treatment and resistance: Can development of treatment-resistance be prevented in schizophrenia?

Baybars VEZNEDAROĞLU

Pharmacotherapeutic approaches in approaches in treatment-resistant schizophrenics

Ender TANER

Psychosocial approaches in treatment-resistant schizophrenics

Mustafa YILDIZ

16:30-17:15

Moderator:

M.Kerem DOKSAT

Optimizing clozapine treatment

David OSSER

17:30-18:15

Moderator:

Feyza ARICIOĞLU

Does the glutamatergic system play a role in the pathophysiology of mood disorders? Results from a clinical approach testing this hypothesis

Jorge QUIROZ

18:30-20:30

Educational Interactive Course

Fundamental biostatistics course

Cengiz AÇIKEL, Selim KILIÇ, Numan KONUK

Salon B |

12 March 2009

13:00-14:30

Symposium-2 : Rational approach and treatment strategies in treatment resistant anxiety disorders

Symposia - Educational Updates Track

Moderators:

Bekir Aydın LEVENT

Ali ÇAYKÖYLÜ

Rational approach and treatment strategies in treatment resistant generalized anxiety disorder

Nesrin DİLBAZ

Rational approach and treatment strategies in treatment resistant OCD

Hüsnü ERKMEN

Rational approach and treatment strategies in treatment resistant panic disorders

Neşe KOCABAŞOĞLU

Rational approach and treatment strategies in treatment of resistant social anxiety disorders

Hatice GÜZ

14:45-16:15

Symposium-5 : Serotonin dopamine antagonist antipsychotics in the treatment resistance from childhood to elderly: Their advantages and disadvantages

Symposia - Educational Updates Track

Moderators:

Aytekin SIR

Sefa SAYGILI

Serotonin dopamine antagonist antipsychotics in childhood and adolescent: Can we prevent resistance at the beginning?

Salih ZOROĞLU

Parenteral serotonin dopamine antagonist antipsychotics in treatment of agitation: What do we have in hand?

Ömer BÖKE

Serotonin dopamin antagonists in patients with demetia: Their advantages and disadvantages

Engin EKER

Serotonin dopamin anatagonists in general psychiatry: Their advantages and disadvantages

M. Kerem DOKSAT

18:30-20:30

Educational Interactive Course

Cognitive functions in schizophrenia and recovery with drugs

Herbert Y. MELTZER

Salon C |

12 March 2009

13:00-14:30

Symposium-3 : Psychotraumatology, psychotherapy, pharmacotherapy: Questions, problems, mastery and expertise

Symposia - Educational Updates Track

Moderators:

Yusuf ALPER

Hakan TÜRKÇAPAR

Unseen part of the iceberg: The role of childhood traumas in resistant psychiatric disorders

Ümit Başar SEMİZ

The role and highlights of pharmacotherapeutic applications in resistant childhood traumas (DID, etc)

Vedat ŞAR

The role of pharmacotherapy in post-traumatic stress disorder: When, with and which drugs and how?

Oğuz KARAMUSTAFALIOĞLU

Does pharmacotherapy support or hinder psychotherapy? Questions, problems, mastery and expertise

Axel WUERZ

14:45-16:15

Neurobiology of Anxiety, Panic, and Fear: Where are we going?

Symposia - Dual Conference

Moderators:

Mustafa BİLİCİ

Özcan UZUN

Periaqueductal gray matter, fear-like behaviour and drug effects

Lee Wei LIM

Neural pathways involved in fear, panic and anxiety

Nazan AYDIN

18:30-20:30

Educational Interactive Course

Psychopharmacological treatment of children and adolescents

Melissa DELBELLO

Salon A |

13 March 2009

07:45-08:45

Educational Interactive Course

Brain stimulation treatments for treatment-resistant depression

Ziad NAHAS

09:00-10:30

Symposium-6 : Treatment resistance in bipolar disorders in all dimensions

Symposia Educational Updates Track

Moderators:

Sunar BİRSÖZ

Medaim YANIK

The concept of treatment response from prodromal phase to resistance and the predictors in bipolar disorders

Kaan KORA

The reflections of treatment on brain imaging in mood disorders

Ayşegül ÖZERDEM

Subsyndromal signs and their effects on the therapeutic response in bipolar disorders

Timuçin ORAL

To overcome treatment resistance in bipolar disorders: What can be done?

Olcay YAZICI

11:00-11:45

Moderator:

İlhan YARĞIÇ

New developments in the treatment of alcoholism

Donald Hugh MYRICK

13:15-14:45

Symposium-9 : Changes in the tendency of prescribing psychopharmacological drugs

Educational Updates Track

Moderators:

Rüstem AŞKIN

Fatih KARAASLAN

Changes between 2005-2007; general data Social Insurance Institute of Turkey

Hasan KARADAĞ

Factors determining prescribing tendencies

Sibel ORSEL

Pharmacoeconomic analysis of prescribing tendencies

Zafer GÜNEY

Drug industry-physician relations: Non-ethical factors that can influence drug prescribing tendencies

Hanefi ÖZBEK

What can be done against unethical prescribing tendencies of psychotrophic drugs?

İbrahim BALCIOĞLU

15:00-15:45

Moderator:

Haluk SAVAŞ

The pharmacologic management of treatment-resistant depression: Realities and fiction?

Andrew NIERENBERG

17:30-18:15

Moderator:

Yankı YAZGAN

Treatment-resistant cases in child and adolescent psychopharmalogy: Treatment and management

Melissa DELBELLO

18:30-21:00

Management of acute agitation in emergency settings

Jimmi NIELSEN

Salon B |

13 March 2009

09:00-10:30

Symposium-7 : The variations of the response, adverse effects and neuroendocrine profile among antidepressants according to their action mechanisms

Treatment Track

Moderators:

İsmail AK

İsmet KIRPINAR

Selçuk KIRLI

Cengiz AKKAYA

Adverse effects and tolerability profile: Similarities and differences

Yusuf SİVRİOĞLU

Saygın EKER

13:15-14:45

Symposium-10 : Addiction:Pharmacotherapy and other approaches in comorbid conditions

Educational Updates Track

Moderators:

Musa TOSUN

Zehra ARIKAN

Pharmacotherapy alternatives in comorbid psychosis

Abdurrahman ALTINDAĞ

Pharmacotherapy alternatives in comorbid mood disorders

Ali DORUK

Pharmacotherapy alternatives in comorbid anxiety disorders

Cüneyt EVREN

Comprehensive therapeutic approaches in stress sensitivity and comorbid conditions in addiction

Berna ULUĞ

Childhood traumas in alcoholism

Hasan MIRSAL

18:30-21:00

Educational Interactive Course

Preparation of scientific papers in psychiatry

Murad ATMACA, Hasan HERKEN

Salon C |

13 March 2009

09:00-10:30

Symposium-8 : Are many of psychiatric disorders are actually impulse control disorders?

Educational Updates Track

Moderators:

Fuat ÖZGEN

Nihat ALPAY

Relationship between impulsivity and personality disorders

Servet EBRİNÇ

Relationship between impulsivity and obsessive compulsive disorder

Berna Binnur KIVIRCIK AKDEDE

Relationship between impulsivity and eating disorders

Fulya MANER

Relationship between impulsivity and suicidal behavior

Levent SEVİNÇOK

Relationship between impulsivity and addiction

Ertuğrul EŞEL

13:15-14:45

Symposium-11 : From childhood to elderly: Comorbid conditions and treatment masteries in treatment resistance

Educational Updates Track

Moderators:

Meral BERKEM

Işın BARAL KULAKSIZOĞLU

Treatment strategies in ADHD and behavioral disorders

Osman SABUNCUOĞLU

ADHD's longterm impact in adulthood: Comorbidities, functionality and therapeutic dilemmas

Yankı YAZGAN

Treatment strategies in schizobsessive conditions

M. Murat DEMET

Pharmacological treatment strategies in elderly with comorbid medical conditions

Ayhan ALGÜL

18:30-21:00

Educational Interactive Course

Neuro-biological signs of therapy on the brain: Pharmacotherapy and cognitive therapy

Hakan TÜRKÇAPAR, Ali Saffet GÖNÜL

Salon A |

14 March 2009

09:00-10:45

Symposium-12 : Pharmacological treatment approaches and recent advances in sexual function disorders

Symposia - Educational Updates Track

Moderators:

Hamdullah AYDIN

Hayrettin KARA

The use of PDE5 inhibitors in treatment of erectile dysfunction is over 10 years. Where did we come in 10 years? Most recent pharmacological approaches

Lut TAMAM

Testestrone replacement therapies and what is the role of DHEA on the treatment of sexual frigidity in male and females?

Tayfun TURAN

What is “elderly hypogonadism” in man? What is the relationship of this with depression and sexual problems in man over 40

Selami ALBAYRAK

What are the positive and negative roles of antidepressants in sexual life

Ömer GEÇİCİ

11:00-11:45

Moderator:

Ali Saffet GÖNÜL

Treatment resistant depression: The role of bipolar misdiagnosis

Nassir GHAEMI

13:15-14:45

Symposium-15 : How effective and ethical are the use of off-label treatments in resistant psychiatric disorders?

Symposia - Educational Updates Track

Moderators:

Orhan DOĞAN

Aytekin ÖZŞAHİN

The high dose and combine antipsychotic applications in refractory schizophrenia

Alp ÜÇOK

The off- label drug use in addiction treatment (antidepressants, anticonvulsants etc.)

Hakan ÇOŞKUNOL

The off- label drug use in resistant bipolar disorders (protective antipsychotic, multiple anticonvulsants and augmentations)

Ömer AYDEMİR

The off-label drug use in resistant anxiety disorders (antipsychotics, anticonvulsants, long-term benzodiazepines and augmentations)

Tunç ALKIN

16:15-17:00

Moderator:

Ayşegül YILDIZ

Effectiveness of adjunctive antidepressant treatment for bipolar depression

Gary SACHS

17:00-17:45

Moderator:

Oğuz KARAMUSTAFALIOĞLU

IPL-10 : Use and misuse of antipsychotics (typical and atypical) in resistant anxiety

Joseph ZOHAR

Salon B |

14 March 2009

09:00-10:45

Symposium-13 : From childhood and adolescence to adulthood: Treatment resistance and new solutions

Symposia - Treatment Track

Moderators:

Kemal AYDINALP

Mücahit ÖZTÜRK

Psychopharmacolgical approaches in autism spectrum disorders: Treatment resistance symptom

Nahit Motavallı MUKADDES

Resistance and solutions in depression and bipolar disorder

Tümer TÜRKBAY

Resistance and solutions in anxiety disorders

Yasemen IŞIK TANER

Resistance and solutions in ADHD

Özgür ÖNER

Resistance and solutions in adult ADHD

Bengi SEMERCİ

13:15-14:45

Symposium-16 : Non-antidepressant treatment strategies in treatment resistant anxiety disorders: From older to new choices

Symposia - Treatment Track

Moderators:

Müfit UĞUR

Salih BATTAL

The role of benzodiazepines in treatment resistant anxiety disorders

Nurper ERBERK ÖZEN

The role of atypical antipsychotics in resistant anxiety disorders

Şebnem PIRILDAR

The role of anticonvulsants in resistant anxiety disorders

Raşit TÜKEL

The role of complimentary medicine to avoid the adverse effects of long term drug use in resistant anxiety disorders

Armağan SAMANCI

18:00-19:00

Educational Interactive Course

Management of treatment resistant schizophrenia

Herbert Y. MELTZER

Salon C |

14 March 2009

09:00-10:45

Symposium-14 : What do studies on the effectiveness and efficacy of psychotropic agents supported by the state and industry (i.e. CATIE, CAFE,EUFEST, CutLaSS, BOLDER I and II,STEP-BD, STAR-D) carried out after 2000 suggest? How should we understand and interpret the data from these studies ?

Symposia - Educational Updates Track

Moderators:

M. Yücel AĞARGÜN

Mesut ÇETİN

The correct reading and interpretation of scientific papers: The principles and suggestions

Selim KILIÇ

From research to clinical experiences:Are antidepressants inefficent in the bipolar depression? Don't they cause manic shift as expected? The correct interpretation of STEP-BD

Haluk SAVAŞ

Atypical antipsychotics for the treatment of bipolar mania. How can we understand and interpret the results of scientific researches ( BOLDER-I and BOLDER-II, etc.)?

Ayşegül YILDIZ

On the typical and atypical antipsychotics in the light of meta-analyses and our clinical experiences :Myths and realities; the correct interpretations of CATIE, CAFE,EUFEST,CutLaSS,etc.

Haldun SOYGÜR

13:15-14:45

Symposium-17 : Accurate reading and comments on meta-analyzes of Kirch and Leucth et al.

Symposia - Educational Updates Track

Moderators:

Nevzat YÜKSEL

M. Kemal SAYAR

Where does the effectiveness of placebo stem from?

Erol GÖKA

Is the efficacy of the antidepressants significantly indifferent than placebo? Comments with regard to the meta-analysis of Kirsh et al.

Numan KONUL

Can "a country bias" be claimed in meta-analysis and comparative studies of drugs in the context of clomipramine and amisulpride examples?